Search
  • Search


    REQUEST FOR INFORMATION: Flow cytometry antibodies and reagents

    HUS-yhtymä

    REQUEST FOR INFORMATION: Flow cytometry antibodies and reagents

    1. Planning notice published

      Aug 6, 10:09 AMAugust 6, 2026 10:09 AM
    2. Planned competition start

      Sep 30, 12:00 AMSeptember 30, 2026 12:00 AM

    Brief

    Finland: Tenders/HUS-yhtymä/REQUEST FOR INFORMATION: Flow cytometry antibodies and reagents

    Planned

    The competition has not been announced yet.

    Deadline
    Sep 30,Expired
    Agreement
    Buying goods

    Brief

    HUS-yhtymä is planning the procurement of flow cytometry antibodies and reagents for immunophenotyping in the Special Hematology Unit laboratory. Suppliers can provide feedback by sending a message along with the completed Appendix 1 to the email address kilpailutus.tiimi@hus.fi, indicating which of the listed antibodies and reagents are available in their product portfolio.

    Medisinsk og laboratorieutstyr

    Register interest in Tarjouspalvelu

    Custom Assessment Criteria

    • Get answers to your bid/no-bid criteria

      Set them up once and Cobrief answers them in every tender

    Will you bid?

    The agent sets up the bid and writes the first draft. Free for 14 days.

    Previous winners

    • Who are you up against?

      The suppliers who have won similar contracts at HUS-yhtymä

    From the notice

    • With this request for information, HUS Helsinki University Hospital (hereinafter HUS) continues the market consultation related to the preparation of the procurement. This request for information follows the previously published request for information entitled "HUS 570-2025 / REQUEST FOR INFORMATION: ANTIBODIES FOR FLOW CYTOMETRY" and focuses on additional antibodies and reagents that were not included in the earlier market consultation. The aim is to identify suppliers that can provide the antibodies listed in Appendix 1 and to gather further market information to support procurement planning. SUBJECT OF PROCUREMENT The antibodies for flow cytometry and reagents subject to this market consultation are used in immunophenotyping in the Special Hematology Unit laboratory of the HUS Diagnostic Center. The products are listed in the attached Appendix (Appendix 1 HUS 570-2025 Antibodies and reagents, part 2). Respondents are asked to indicate which of the antibodies and reagents listed in Appendix 1 are available in their product portfolio and provide the requested product information. INSTRUCTIONS FOR ANSWERING Respondents are kindly asked to send a message along with the completed Appendix 1 to the email address: kilpailutus.tiimi@hus.fi. The appendix can be found in the Cloudia Supplier Portal. The link to the Portal is situated in "Participation" -page of the prior information notice at www.hankintailmoitukset.fi. At TED database the link can be found in section "Procurement documents" of the prior information notice. SCHEDULE FOR RESPONDING Responses should be submitted by 19.8.2026 12:00 GMT+2 at the latest. The title or message field of the e-mail should mention: HUS 570-2025 Antibodies for flow cytometry part 2. INFORMATION FOR THE PROCEDURE This request for information is not a contract notice, a prior information notice, or a call for tenders, and the publication of this notice does not initiate a procurement procedure. The request for information does not oblige the contracting entity to carry out the actual procurement. Neither the request for information nor any responses submitted thereto shall be binding on either party. The costs associated with responding to a request for information are borne by the respondent, and HUS does not pay compensation for responding to a request for information or participating in the procurement procedure. The responses provided by suppliers will be treated confidentially.

    • Contact

      KilpailutustiimiKILPAILUTUS.TIIMI@HUS.FI
    • Type
      Planning
    • Main code
      Reagents and contrast media
      33696000

    Similar active competitions

    • HUS-yhtymä

      Medisinsk og laboratorieutstyr

      REQUEST FOR INFORMATION: SPRI Beads

      HUS-yhtymä is planning the procurement of DNA size selection reagents based on paramagnetic beads, utilizing SPRI technology for selective binding and purification of DNA fragments, to be used in next-generation sequencing (NGS) library preparation. Suppliers can provide feedback and input by submitting a response via email to kilpailutus.diagnostiikka@hus.fi, addressing all requirements, providing requested information and documentation, and identifying any concerns or proposed amendments to the draft agreement.

      Planning
      Nov 1, 2026(3 days)
    • HUS-yhtymä

      Laboratorie-kits og reagenser

      Automaattinen nukleiinihappojen eristyslaite

      HUS-yhtymä suunnittelee automaattisen nukleiinihappojen eristyslaitteen hankintaa HUS Diagnostiikkakeskuksen Kliinisen mikrobiologian nukleiinihappoanalytiikkaan, sisältäen laitteen, varalaitteen tai kaksi erillistä eristysmoduulia sekä tarvittavat reagenssit ja tarvikkeet. Hankittavalla laitteella on tarkoitus eristää bakteeri-DNA:ta useista eri näytemateriaaleista, ja eristetyn tuotteen tulee olla validoitu bakteerien 16S-geenin PCR-monistamiseen Sanger-sekvensoinnilla. Toimittajia pyydetään tutustumaan liitteenä oleviin kysymyksiin ja toimittamaan vastaukset sähköpostitse osoitteeseen kilpailutus.diagnostiikka@hus.fi. bioMérieux Suomi OY:llä on todennäköisesti sopimus tällä hetkellä.

      Planning
      Jan 16, 2027(79 days)
    • HUS-yhtymä

      Medisinsk og laboratorieutstyr

      Request for information: Radioactive seeds (I-125) and plaques (Ru-106) used in eye brachytherapy

      HUS Group is planning the procurement of radioactive products, specifically Iodine-125 (I-125) brachytherapy seeds and Ruthenium-106 (Ru-106) eye plaques/applicators, along with related accessories for the treatment of epibulbar and intraocular tumors. Suppliers are asked to provide information on their product portfolios, typical delivery times, and available options for accessories, quality assurance, and treatment planning systems by submitting their responses via email to kilpailutus.tiimi@hus.fi. Eckert & Ziegler BEBIG GmbH likely has the contract today.

      Planning
      Jan 25, 2027(88 days)